ND Biosciences’ publishes a new paper in collaboration with the EPFL and ADX NeuroScience describing thorough characterization of
ND Biosciences’ publishes a new paper in collaboration with the EPFL and ADX NeuroScience describing thorough characterization of
ND Biosciences awarded a grant from The Michael J. Fox Foundation to accelerate the development of its assays
ND-BioSciences Announces partnership with The Michael J. Fox Foundation for parkinson’s research to make available unique synuclein proteoforms
ND BioSciences, a Swiss-based biotechnology company that was
ND BioSciences, the Swiss biotech co-founded by Prof. Hilal Lashuel, the director of the laboratory of molecular and chemical biology
La start-up qui veut combattre les maladies neurodégénératives par des traitements novateurs
The biotech start-up based at Biopôle is developing innovative technologies for early diagnostics and therapies
The development of disease models that recapitulate the key pathological and clinical features of neurodegenerative diseases
ND BioSciences, the Swiss biotech co-founded by Prof. Hilal Lashuel, the director of the laboratory of molecular and chemical biology
ND BioSciences, a Swiss-based biotechnology company that was
ND BioSciences, a Swiss-based biotechnology company that was